Literature DB >> 9068651

Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway.

S A Hyland1, S S Eveland, M S Anderson.   

Abstract

The lpxC (envA) gene of Escherichia coli encodes UDP-3-O-acyl-GlcNAc deacetylase, the second and committed step of lipopolysaccharide biosynthesis. Although present in all gram-negative bacteria examined, the deacetylase from E. coli is the only example of this enzyme that has been expressed and purified. In order to examine other variants of this protein, we cloned the Pseudomonas aeruginosa deacetylase structural gene from a lambda library as a 5.1-kb EcoRI fragment. The LpxC reading frame encodes an inferred protein of 33,435 Da that is highly homologous to the E. coli protein and that possesses a nearly identical hydropathy profile. In order to verify function, we subcloned the P. aeruginosa lpxC gene into the T7-based expression vector pET11a. Upon induction at 30 degrees C, this construct yielded active protein to approximately 18% of the soluble fraction. We devised a novel, rapid, and reproducible assay for the deacetylase which facilitated purification of the enzyme in three steps. The purified recombinant protein was found to be highly sensitive to EDTA yet was reactivated by the addition of excess heavy metal, as was the case for crude extracts of P. aeruginosa. In contrast, deacetylase activity in crude extracts of E. coli was insensitive to EDTA, and the extracts of the envA1 mutant were sensitive in a time-dependent manner. The lpxC gene has no significant homology with amidase signature sequences. Therefore, we assign this protein to the metalloamidase family as a member with a novel structure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068651      PMCID: PMC178929          DOI: 10.1128/jb.179.6.2029-2037.1997

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Sequence analysis, transcriptional organization, and insertional mutagenesis of the envA gene of Escherichia coli.

Authors:  B Beall; J Lutkenhaus
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

2.  Antibacterial agents that inhibit lipid A biosynthesis.

Authors:  H R Onishi; B A Pelak; L S Gerckens; L L Silver; F M Kahan; M H Chen; A A Patchett; S M Galloway; S A Hyland; M S Anderson; C R Raetz
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  Profile analysis: detection of distantly related proteins.

Authors:  M Gribskov; A D McLachlan; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Progressive sequence alignment as a prerequisite to correct phylogenetic trees.

Authors:  D F Feng; R F Doolittle
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

5.  Buffers of constant ionic strength for studying pH-dependent processes.

Authors:  K J Ellis; J F Morrison
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography.

Authors:  H G Bull; N A Thornberry; E H Cordes
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

7.  Similarity of tuna N-acetylhistidine deacetylase and cod fish anserinase.

Authors:  J F Lenney; M H Baslow; G H Sugiyama
Journal:  Comp Biochem Physiol B       Date:  1978

8.  Isolation and characterization of Escherichia coli strains defective in CDP-diglyceride hydrolase.

Authors:  C E Bulawa; C R Raetz
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

9.  The biosynthesis of gram-negative endotoxin. Formation of lipid A precursors from UDP-GlcNAc in extracts of Escherichia coli.

Authors:  M S Anderson; C E Bulawa; C R Raetz
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  9 in total

1.  Escherichia coli strains blocked in Tat-dependent protein export exhibit pleiotropic defects in the cell envelope.

Authors:  N R Stanley; K Findlay; B C Berks; T Palmer
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.

Authors:  Brian E Coggins; Xuechen Li; Amanda L McClerren; Ole Hindsgaul; Christian R H Raetz; Pei Zhou
Journal:  Nat Struct Biol       Date:  2003-08

3.  Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.

Authors:  Khisimuzi E Mdluli; Pamela R Witte; Toni Kline; Adam W Barb; Alice L Erwin; Bryce E Mansfield; Amanda L McClerren; Michael C Pirrung; L Nathan Tumey; Paul Warrener; Christian R H Raetz; C Kendall Stover
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Mammalian PIG-L and its yeast homologue Gpi12p are N-acetylglucosaminylphosphatidylinositol de-N-acetylases essential in glycosylphosphatidylinositol biosynthesis.

Authors:  R Watanabe; K Ohishi; Y Maeda; N Nakamura; T Kinoshita
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

5.  Optimization of theoretical maximal quantity of cells to immobilize on solid supports in the rational design of immobilized derivatives strategy.

Authors:  Freddy Castillo-Alfonso; Marcia M Rojas; Irina Salgado-Bernal; María E Carballo; Roberto Olivares-Hernández; Jorge González-Bacerio; José M Guisán; Alberto Del Monte-Martínez
Journal:  World J Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 3.312

6.  Antibacterial activities and characterization of novel inhibitors of LpxC.

Authors:  John M Clements; Fanny Coignard; Ian Johnson; Stephen Chandler; Shilpa Palan; Andrew Waller; Jac Wijkmans; Michael G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli.

Authors:  Adam W Barb; Amanda L McClerren; Karnem Snehelatha; C Michael Reynolds; Pei Zhou; Christian R H Raetz
Journal:  Biochemistry       Date:  2007-03-03       Impact factor: 3.162

8.  Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC.

Authors:  Adam W Barb; Tanya M Leavy; Lori I Robins; Ziqiang Guan; David A Six; Pei Zhou; Matthew J Hangauer; Carolyn R Bertozzi; Christian R H Raetz
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

9.  Global regulation of gene expression by OxyR in an important human opportunistic pathogen.

Authors:  Qing Wei; Phu Nguyen Le Minh; Andreas Dötsch; Falk Hildebrand; Warunya Panmanee; Ameer Elfarash; Sebastian Schulz; Stéphane Plaisance; Daniel Charlier; Daniel Hassett; Susanne Häussler; Pierre Cornelis
Journal:  Nucleic Acids Res       Date:  2012-01-24       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.